GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Cyclically Adjusted Price-to-FCF

China National Accord Medicines (SZSE:000028) Cyclically Adjusted Price-to-FCF : 17.04 (As of May. 26, 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Cyclically Adjusted Price-to-FCF?

As of today (2024-05-26), China National Accord Medicines's current share price is ¥38.33. China National Accord Medicines's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥2.25. China National Accord Medicines's Cyclically Adjusted Price-to-FCF for today is 17.04.

The historical rank and industry rank for China National Accord Medicines's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:000028' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 12.29   Med: 52.74   Max: 442.21
Current: 17.06

During the past years, China National Accord Medicines's highest Cyclically Adjusted Price-to-FCF was 442.21. The lowest was 12.29. And the median was 52.74.

SZSE:000028's Cyclically Adjusted Price-to-FCF is ranked better than
68.75% of 32 companies
in the Medical Distribution industry
Industry Median: 26.27 vs SZSE:000028: 17.06

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

China National Accord Medicines's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥-1.271. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥2.25 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


China National Accord Medicines Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for China National Accord Medicines's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Cyclically Adjusted Price-to-FCF Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.03 28.64 19.34 13.63 13.07

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.33 21.59 15.59 13.07 13.67

Competitive Comparison of China National Accord Medicines's Cyclically Adjusted Price-to-FCF

For the Medical Distribution subindustry, China National Accord Medicines's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's Cyclically Adjusted Price-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Cyclically Adjusted Price-to-FCF falls into.



China National Accord Medicines Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

China National Accord Medicines's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=38.33/2.25
=17.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Accord Medicines's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, China National Accord Medicines's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.271/115.2271*115.2271
=-1.271

Current CPI (Mar. 2024) = 115.2271.

China National Accord Medicines Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.290 98.200 -0.340
201409 -0.463 98.900 -0.539
201412 -0.669 99.000 -0.779
201503 0.282 99.900 0.325
201506 0.491 99.500 0.569
201509 -0.216 100.500 -0.248
201512 1.136 100.600 1.301
201603 -0.094 102.200 -0.106
201606 1.382 101.400 1.570
201609 -0.098 102.400 -0.110
201612 0.996 102.600 1.119
201703 -0.975 103.200 -1.089
201706 1.228 103.100 1.372
201709 0.428 104.100 0.474
201712 1.250 104.500 1.378
201803 -1.636 105.300 -1.790
201806 1.887 104.900 2.073
201809 0.514 106.600 0.556
201812 1.178 106.500 1.275
201903 -1.515 107.700 -1.621
201906 3.369 107.700 3.604
201909 -0.237 109.800 -0.249
201912 1.559 111.200 1.615
202003 -1.324 112.300 -1.359
202006 3.695 110.400 3.857
202009 0.852 111.700 0.879
202012 -1.046 111.500 -1.081
202103 -0.664 112.662 -0.679
202106 2.597 111.769 2.677
202109 0.170 112.215 0.175
202112 0.192 113.108 0.196
202203 -0.528 114.335 -0.532
202206 2.131 114.558 2.143
202209 1.663 115.339 1.661
202212 0.747 115.116 0.748
202303 0.251 115.116 0.251
202306 2.139 114.558 2.151
202309 -0.164 115.339 -0.164
202312 2.448 114.781 2.458
202403 -1.271 115.227 -1.271

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China National Accord Medicines  (SZSE:000028) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


China National Accord Medicines Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines